Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.8850 (3.14%) ($7.8850 - $7.9100) on Wed. Jul. 26, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.92% (three month average) | RSI | 67 | Latest Price | $7.8850(3.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.2% a day on average for past five trading days. | Weekly Trend | BCRX advances 2.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(32%) BND(22%) VCIT(22%) SLV(21%) IBB(20%) | Factors Impacting BCRX price | BCRX will decline at least -1.46% in a week (0% probabilities). XLRE(-33%) XLP(-28%) DIA(-25%) XLI(-23%) SPLV(-22%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.46% (StdDev 2.92%) | Hourly BBV | 1.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.5(5.13%) | 10 Day Moving Average | $7.39(6.7%) | 20 Day Moving Average | $7.25(8.76%) | To recent high | -11% | To recent low | 13.6% | Market Cap | $1.391b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |